FDx Advisors Inc. purchased a new stake in Omega Healthcare Investors Inc (NYSE:OHI) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,634 shares of the real estate investment trust’s stock, valued at approximately $233,000.
A number of other institutional investors and hedge funds have also made changes to their positions in OHI. Daiwa Securities Group Inc. boosted its holdings in Omega Healthcare Investors by 14,906.5% in the fourth quarter. Daiwa Securities Group Inc. now owns 2,929,265 shares of the real estate investment trust’s stock valued at $80,672,000 after purchasing an additional 2,909,745 shares in the last quarter. Lasalle Investment Management Securities LLC acquired a new position in Omega Healthcare Investors in the fourth quarter valued at approximately $59,033,000. LSV Asset Management boosted its holdings in Omega Healthcare Investors by 106.1% in the fourth quarter. LSV Asset Management now owns 4,006,633 shares of the real estate investment trust’s stock valued at $110,342,000 after purchasing an additional 2,062,428 shares in the last quarter. Deutsche Bank AG boosted its holdings in Omega Healthcare Investors by 348.1% in the fourth quarter. Deutsche Bank AG now owns 2,178,808 shares of the real estate investment trust’s stock valued at $59,998,000 after purchasing an additional 1,692,622 shares in the last quarter. Finally, Allianz Asset Management GmbH boosted its holdings in Omega Healthcare Investors by 624.5% in the fourth quarter. Allianz Asset Management GmbH now owns 558,527 shares of the real estate investment trust’s stock valued at $15,382,000 after purchasing an additional 481,438 shares in the last quarter. 73.92% of the stock is owned by hedge funds and other institutional investors.
Shares of Omega Healthcare Investors opened at $28.42 on Friday, according to MarketBeat. The company has a debt-to-equity ratio of 1.20, a current ratio of 4.01 and a quick ratio of 4.01. Omega Healthcare Investors Inc has a twelve month low of $24.90 and a twelve month high of $34.84. The company has a market capitalization of $5.63 billion, a price-to-earnings ratio of 8.61, a PEG ratio of 3.21 and a beta of 0.35.
Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Monday, May 7th. The real estate investment trust reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.05. Omega Healthcare Investors had a return on equity of 2.02% and a net margin of 8.94%. The company had revenue of $193.90 million during the quarter, compared to analysts’ expectations of $194.60 million. During the same quarter in the previous year, the business earned $0.86 earnings per share. The firm’s revenue for the quarter was up .7% on a year-over-year basis. sell-side analysts anticipate that Omega Healthcare Investors Inc will post 2.95 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 15th. Stockholders of record on Monday, April 30th were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 9.29%. The ex-dividend date was Friday, April 27th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 80.00%.
A number of equities research analysts have weighed in on the company. Jefferies Group upgraded Omega Healthcare Investors from an “underperform” rating to a “hold” rating and set a $27.00 price objective for the company in a research note on Wednesday. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday. ValuEngine cut Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Raymond James assumed coverage on Omega Healthcare Investors in a research note on Wednesday, April 25th. They issued a “market perform” rating for the company. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $34.00 price objective on shares of Omega Healthcare Investors in a research note on Wednesday, March 7th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $31.00.
Omega Healthcare Investors Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.